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In reviewing any technical book it is inevitable to approach it with
some preconceptions. The title ‘Combined Modality Therapy of
Central Nervous System Tumours’ would lead me to expect some
introductory chapters that describe the tumours themselves with an
introduction to the techniques involved in their management.
I would expect the bulk of the book to comprise a critical review
of current management techniques for individual tumours with a
view of how these may be integrated into a state of the art, multi-
modality approach to therapy. Such a book involving many
authors needs careful editing if it is to make sense. How does this
book match up? 
The introductory chapters are much as expected but are of
mixed quality. An excellent chapter on epidemiology is followed
by an inadequate, incomplete and poorly referenced pathology
chapter. There are three very good chapters on radiobiology, the
physics of external beam radiotherapy and stereotaxy that intro-
duce basic principles in radiotherapy. The chapter on stereotaxy is
particularly good. This introduction works very well and facili-
tates an understanding of the radiotherapy applications that arise in
later chapters. Strangely, however, there is no similar introduction
to surgical or chemotherapy techniques and the reader is left to
fend for himself when some quite complex ideas with respect
to these modalities occur in later, tumour orientated chapters.
Likewise, the imaging chapter represents a missed opportunity.
There is no useful introduction to the standard techniques and no
worthwhile discussion of the newer imaging methods (functional
MRI, PET, and SPECT) and how they may be incorporated into
the management of brain tumours. Rather, the chapter takes a
familiar approach of describing many different tumour types in
terms of MRI based imaging (T1, T2 and T1/Gd appearances) and
includes a lot of unnecessary clinical material which is available
elsewhere in the book. Also surprising is the failure to discuss
certain rare tumours that have characteristic imaging fingerprints
such as central neurocytoma and gliomatosis cerebri. 
There follows a series of chapters dedicated to the management
of individual tumours. These are wide ranging and cover benign
tumours (pituitary tumours, craniopharyngioma, vestibular Sch-
wannoma and meningioma), the more common malignant tumours
and rarer tumours, though many of these latter only briefly. Some
of the common tumours are given separate chapters devoted
to surgical, radiotherapeutic and, sometimes, chemotherapeutic
perspectives. This format does produce some very good authorita-
tive writing in places but inevitably leads to considerable and
annoying repetition. For example Simpson grading for menin-
gioma is listed twice in consecutive chapters and the principles of
stereotactic radiotherapy appear ubiquitously! The balance
of these chapters is uneven, as if the authors had not read their
editor’s instructions. In some we are given a great deal of technical
detail on how a particular procedure is performed, in others very
little. Some convincing chapters are spoiled when the author
succumbs to the temptation to wander away from his own dis-
cipline with accompanying loss of authority. For example, the
surgeons writing on pituitary treatment attempt to discuss radio-
therapeutic management using outdated references and end by
giving advice that is immediately contradicted in the following
(radiotherapy) chapter. 
There are some gems to be found. Chapter 14, on low grade
brain tumours, tackles a very difficult subject extremely well. It is
thoughtful and comprehensive in its literature review. It discusses
the value of individual therapies without contradiction and offers
guidelines that are clear, workable and credible. It is a model of
how to write a chapter on multi-modality therapy. Unfortunately,
not all chapters address the task in the same way, nor are they so
objective. For example Chapter 23, on primary CNS lymphoma,
spends more time discussing presentation than treatment and fails
to give any clear guidelines on management. 
There are many additional annoyances in this book. Although it
is comprehensively referenced, many of the articles are described
in the body of the text which makes for difficult and tedious
reading. Whilst this can be justified if adequate criticism of the
referenced article is given, often this is not the case and the infor-
mation could have been better delivered in the form of carefully
constructed tables. There are too many examples of ‘loose’
writing. Stereotactic irradiation is not the ‘delivery of a single high
doses of radiation’; rather it is a means of irradiation which uses
stereotactic localization techniques. Personal prejudice too often
overrides objectivity. It is irresponsible to say that ‘clinical studies
have shown a consistent improvement in two year survival (in
glioma) with the use of a stereotactic boost.’ when no appropriate
randomized studies have been done and selection bias could
equally well explain the results. The allocation of space is uneven.
Craniopharyngioma is given 2 chapters, 42 pages and 5 authors,
whilst pineal region tumours, which demand high levels of multi-
modality integration in their management, are distributed in small
sections over several chapters (on paediatrics, rare tumours and
chemotherapy) without any attempt at integration. 
Whilst there is much in this book that is good, the format and poor
editing lead, on the one hand, to much repetition and on the other to
the omission or under-representation of some important topics. There
is conflicting advice, sometimes in adjacent chapters, which may be
very confusing to the newcomer to neuro-oncology. There are
already good books available on many of the topics covered here and
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end this is probably more a book for the already experienced practi-
tioner who can read through the bias of some of the individual
contributors to get at some of the very good information that is avail-
able. Future editions should concentrate on smoothing out the writing
and providing a true multi-modality perspective. 
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